Related Experiment Videos
Reactional tattoo inoculation borderline tuberculoid leprosy with oedematous tattoos
1Department of Dermatology, Venereology & Leprology, JLN Hospital & Research Centre, Bhilai Steel Plant, Bhilai, Chattisgarh 490006, India. draghorpade@yahoo.com
Leprosy Review
|April 10, 2004
Summary
Tattoo inoculation leprosy, a rare form of borderline tuberculoid leprosy, can manifest with significant swelling after starting treatment. Prompt management with steroids and multidrug therapy leads to excellent patient outcomes.
Area of Science:
- Dermatology
- Infectious Diseases
- Immunology
Background:
- Leprosy is a chronic infectious disease caused by Mycobacterium leprae.
- Borderline tuberculoid (BT) leprosy represents a form of the disease with features of both lepromatous and tuberculoid leprosy.
- Paucibacillary multidrug therapy (PB MDT) is the standard treatment for BT leprosy.
Observation:
- A case of borderline tuberculoid leprosy presenting with prominent edema at the tattoo site after initiating PB MDT is described.
- This specific presentation, termed tattoo inoculation leprosy, is rare.
- Histopathological examination confirmed the diagnosis.
Findings:
- The patient experienced an upgrading reaction during PB MDT, characterized by localized inflammation at the tattoo site.
- Treatment with oral steroids in addition to PB MDT resulted in an excellent clinical response.
- This suggests a localized immune response triggered by the tattoo in the context of leprosy treatment.
Implications:
- Tattoo inoculation leprosy highlights the potential for localized inflammatory reactions at tattoo sites during leprosy treatment.
- Early recognition and management with corticosteroids may be crucial for resolving such reactions.
- Further research is needed to understand the immunopathogenesis of tattoo-associated leprosy reactions.